This work provides evidence that utilizing functional DNA variants of SP-D in clinical association studies, instead of markers of SNPs, advances our understanding of surfactant genetic susceptibility and innate defense mechanisms to pulmonary TB and other lung diseases. Here, SFTPD is linked to lung disorder.